Your English writing platform
Discover LudwigSuggestions(5)
Exact(6)
The top three most reported reasons is highly comparable for both groups and is comparable over the years.
The cumulative incidence of PID cases caused by C. trachomatis is tracked for both groups and is set to zero at model initiation (Additional file 1).
The follow-up duration differs significantly between both groups and is on average less than 1 year in the Blandy group.
The APTC event rate was about 0.85% in both groups, and is similar in magnitude to other results for coxibs and NSAIDs (Table 2).
This risk varies between individual treatments within both groups and is increased with dose and duration of treatment; 3) COX-2 inhibitors are associated with a significantly lower gastrointestinal toxicity compared to tNSAIDs.
Cohen's d is defined as follows: 25 d = x f ¯ − x y ¯ S p o o l e d (2 where x ¯ is the mean (average of treatment or comparison conditions) and S pooled represents the standard deviation of both groups and is given by: S p o o l e d = (n f − 1 ) s f 2 + (n y − 1 ) s y 2 n f + n y (3)where n and s represent the number of subjects and the standard deviation of each group, respectively.
Similar(54)
The MAP was similar in both groups and was maintained above 65 mmHg with fluid and vasopressor support (p > 0.05).
However, this study concludes that other variables are quite independent for both groups, and are not determinant in profiles for high- and low- performance groups.
The median time for apyrexia was two days in both groups and was not shortened by oseltamivir.
At low glucose concentration, insulin secretion was similar in both groups and was not affected by the addition of GLP-1 (Fig. 4A).
Grip strength declined slightly for both groups and was not significant.
More suggestions(16)
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com